Stocks in Action USA: DaVita, Woodward, Teradyne
Reading Time: 3 minutes
DaVita (DVA) – Stable dialysis demand drives profit forecast beyond market expectations! DaVita reports stronger-than-expected growth in the fourth quarter and sends a clear signal of operational recovery with its outlook, significantly boosting the stock. The dialysis services provider benefits from stable demand in its outpatient centers and home dialysis business, achieving an adjusted earnings per share of $3.40, exceeding analyst estimates of around $3.16. CFO Joel Ackerman points out that pressures from the phase-out of certain subsidies...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
